Last Updated : November 18, 2013
Details
FilesGeneric Name:
Aflibercept
Project Status:
Complete
Therapeutic Area:
Macular degeneration, age-related
Manufacturer:
Bayer Canada Inc.
Call for patient/clinician input open:
Brand Name:
Eylea
Project Line:
Reimbursement Review
Project Number:
SR0361-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Macular degeneration, age-related
Recommendation Type:
List with criteria/condition
Final Recommendation:
Files
Last Updated : November 18, 2013